These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 7906175)
21. Serum levels of sulpiride enantiomers after oral treatment with racemic sulpiride in psychiatric patients: a pilot study. Müller MJ; Härtter S; Köhler D; Hiemke C Pharmacopsychiatry; 2001 Jan; 34(1):27-32. PubMed ID: 11229619 [TBL] [Abstract][Full Text] [Related]
22. Determination of a new benzamide, amisulpride, in human plasma by reversed-phase ion-pair high-performance liquid chromatography. Bohbot M; Doare L; Diquet B J Chromatogr; 1987 May; 416(2):414-9. PubMed ID: 2886513 [No Abstract] [Full Text] [Related]
23. Safety and pharmacokinetics of a single oral dose of amisulpride in healthy elderly volunteers. Hamon-Vilcot B; Chaufour S; Deschamps C; Canal M; Zieleniuk I; Ahtoy P; Chretien P; Rosenzweig P; Nasr A; Piette F Eur J Clin Pharmacol; 1998 Jul; 54(5):405-9. PubMed ID: 9754984 [TBL] [Abstract][Full Text] [Related]
24. [Comparative study of the pharmacological properties of sultopride sulpiride and other antipsychotic drugs: influence of sultopride, sulpiride and other antipsychotic drugs on spontaneous locomotor activity and changes in locomotor activity induced by apomorphine and clonidine in mice]. Horikomi K; Fujita M Yakubutsu Seishin Kodo; 1986 Sep; 6(3):339-52. PubMed ID: 2880435 [TBL] [Abstract][Full Text] [Related]
25. Determination of sultopride and tiapride in serum by gas chromatography using a surface ionisation detector. Kamizono A; Inotsume N; Miyamoto K; Ueda K; Miyakawa T; Arimoto H; Nakano M J Chromatogr; 1991 Jun; 567(1):113-20. PubMed ID: 1918238 [TBL] [Abstract][Full Text] [Related]
26. Absorption, distribution and excretion of sultopride in man and several animal species. Kobari T; Iguro Y; Ito T; Namekawa H; Kato Y; Yamada S Xenobiotica; 1985 Jul; 15(7):605-13. PubMed ID: 4049901 [TBL] [Abstract][Full Text] [Related]
27. Effect of sultopride on prolactin secretion in rats. Mizuchi A; Kitagawa N; Saruta S; Tokuda H; Miyachi Y Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):232-40. PubMed ID: 6424592 [TBL] [Abstract][Full Text] [Related]
28. Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds--implications for pharmacokinetics of selected substrates. El Ela AA; Härtter S; Schmitt U; Hiemke C; Spahn-Langguth H; Langguth P J Pharm Pharmacol; 2004 Aug; 56(8):967-75. PubMed ID: 15285840 [TBL] [Abstract][Full Text] [Related]
29. Rapid high-performance liquid chromatographic measurement of amisulpride in human plasma: application to manage acute intoxication. Péhourcq F; Ouariki S; Bégaud B J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jun; 789(1):101-5. PubMed ID: 12726848 [TBL] [Abstract][Full Text] [Related]
30. Estimation of rac-amisulpride transfer into milk and of infant dose via milk during its use in a lactating woman with bipolar disorder and schizophrenia. Teoh S; Ilett KF; Hackett LP; Kohan R Breastfeed Med; 2011 Apr; 6(2):85-8. PubMed ID: 20925494 [TBL] [Abstract][Full Text] [Related]
31. D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: a 123I-iodobenzamide SPECT study. la Fougère C; Meisenzahl E; Schmitt G; Stauss J; Frodl T; Tatsch K; Hahn K; Möller HJ; Dresel S J Nucl Med; 2005 Jun; 46(6):1028-33. PubMed ID: 15937316 [TBL] [Abstract][Full Text] [Related]
32. [Sultopride: a new powerful neuroleptic (author's transl)]. Anglade P; Baraer J Sem Hop; 1979 Jan 8-15; 55(1-2):63-7. PubMed ID: 34217 [TBL] [Abstract][Full Text] [Related]
33. Comparative bioavailability study of amisulpride tablets in healthy Indian volunteers. Das A; Bhaumik U; Chakrabarty US; Sarkar AK; Ghosh A; Bose A; Chatterjee B; Pal TK Arzneimittelforschung; 2009; 59(4):166-70. PubMed ID: 19517892 [TBL] [Abstract][Full Text] [Related]
34. Plasma amisulpride levels in schizophrenia or schizoaffective disorder. Bergemann N; Kopitz J; Kress KR; Frick A Eur Neuropsychopharmacol; 2004 May; 14(3):245-50. PubMed ID: 15056484 [TBL] [Abstract][Full Text] [Related]
35. [Plasma, erythrocyte and urinary pharmacokinetics of sultopride in man]. Bres J; Bressolle F Therapie; 1985; 40(6):433-9. PubMed ID: 4089784 [No Abstract] [Full Text] [Related]
36. [The features of atypical neuroleptic amisulpride action]. Grigor'eva EA; Ritskov AS Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(6):59-64. PubMed ID: 15285638 [No Abstract] [Full Text] [Related]
37. Plasma amisulpride in relation to prescribed dose, clozapine augmentation, and other factors: data from a therapeutic drug monitoring service, 2002-2010. Bowskill SV; Patel MX; Handley SA; Flanagan RJ Hum Psychopharmacol; 2012 Sep; 27(5):507-13. PubMed ID: 22996618 [TBL] [Abstract][Full Text] [Related]
38. Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia. Müller MJ; Regenbogen B; Härtter S; Eich FX; Hiemke C J Psychiatr Res; 2007 Oct; 41(8):673-9. PubMed ID: 16324716 [TBL] [Abstract][Full Text] [Related]
39. Amisulpride doses and plasma levels in different age groups of patients with schizophrenia or schizoaffective disorder. Müller MJ; Eich FX; Regenbogen B; Sachse J; Härtter S; Hiemke C J Psychopharmacol; 2009 May; 23(3):278-86. PubMed ID: 18562411 [TBL] [Abstract][Full Text] [Related]
40. A population approach to characterise amisulpride pharmacokinetics in older people and Alzheimer's disease. Reeves S; Bertrand J; D'Antonio F; McLachlan E; Nair A; Brownings S; Greaves S; Smith A; Taylor D; Howard R Psychopharmacology (Berl); 2016 Sep; 233(18):3371-81. PubMed ID: 27481049 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]